Oncosil Medical Ltd
ASX:OSL

Watchlist Manager
Oncosil Medical Ltd Logo
Oncosil Medical Ltd
ASX:OSL
Watchlist
Price: 1.055 AUD 1.44% Market Closed
Market Cap: 20m AUD

Intrinsic Value

The intrinsic value of one OSL stock under the Base Case scenario is 0.441 AUD. Compared to the current market price of 1.055 AUD, Oncosil Medical Ltd is Overvalued by 58%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

OSL Intrinsic Value
0.441 AUD
Overvaluation 58%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Oncosil Medical Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about OSL?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is OSL valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Oncosil Medical Ltd.

Explain Valuation
Compare OSL to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about OSL?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Oncosil Medical Ltd

Current Assets 6.7m
Cash & Short-Term Investments 5.1m
Receivables 1.2m
Other Current Assets 409.7k
Non-Current Assets 424.2k
PP&E 424.3k
Other Non-Current Assets -100
Current Liabilities 4m
Accounts Payable 1.9m
Accrued Liabilities 432.1k
Other Current Liabilities 1.7m
Non-Current Liabilities 16.2k
Long-Term Debt 16.2k
Efficiency

Free Cash Flow Analysis
Oncosil Medical Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Oncosil Medical Ltd

Revenue
1.3m AUD
Cost of Revenue
-2.3m AUD
Gross Profit
-992k AUD
Operating Expenses
-14m AUD
Operating Income
-15m AUD
Other Expenses
-102.1k AUD
Net Income
-15.1m AUD
Fundamental Scores

OSL Profitability Score
Profitability Due Diligence

Oncosil Medical Ltd's profitability score is 8/100. The higher the profitability score, the more profitable the company is.

8/100
Profitability
Score

Oncosil Medical Ltd's profitability score is 8/100. The higher the profitability score, the more profitable the company is.

OSL Solvency Score
Solvency Due Diligence

Oncosil Medical Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Negative Net Debt
Low D/E
Long-Term Solvency
69/100
Solvency
Score

Oncosil Medical Ltd's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OSL Price Targets Summary
Oncosil Medical Ltd

There are no price targets for OSL.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Oncosil Medical Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for OSL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one OSL stock?

The intrinsic value of one OSL stock under the Base Case scenario is 0.441 AUD.

Is OSL stock undervalued or overvalued?

Compared to the current market price of 1.055 AUD, Oncosil Medical Ltd is Overvalued by 58%.

Back to Top